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Cigarette smoke extract profoundly 
suppresses TNFα-mediated 
proinflammatory gene expression 
through upregulation of ATF3 in 
human coronary artery endothelial 
cells
Jack E. Teasdale1, Georgina G. J. Hazell1, Alasdair M. G. Peachey1, Graciela B. Sala-Newby1,  
Charles C. T. Hindmarch2,3, Tristan R. McKay4, Mark Bond1, Andrew C. Newby1 & 
Stephen J. White4
Endothelial dysfunction caused by the combined action of disturbed flow, inflammatory mediators 
and oxidants derived from cigarette smoke is known to promote coronary atherosclerosis and increase 
the likelihood of myocardial infarctions and strokes. Conversely, laminar flow protects against 
endothelial dysfunction, at least in the initial phases of atherogenesis. We studied the effects of TNFα 
and cigarette smoke extract on human coronary artery endothelial cells under oscillatory, normal 
laminar and elevated laminar shear stress for a period of 72 hours. We found, firstly, that laminar flow 
fails to overcome the inflammatory effects of TNFα under these conditions but that cigarette smoke 
induces an anti-oxidant response that appears to reduce endothelial inflammation. Elevated laminar 
flow, TNFα and cigarette smoke extract synergise to induce expression of the transcriptional regulator 
activating transcription factor 3 (ATF3), which we show by adenovirus driven overexpression, decreases 
inflammatory gene expression independently of activation of nuclear factor-κB. Our results illustrate 
the importance of studying endothelial dysfunction in vitro over prolonged periods. They also identify 
ATF3 as an important protective factor against endothelial dysfunction. Modulation of ATF3 expression 
may represent a novel approach to modulate proinflammatory gene expression and open new 
therapeutic avenues to treat proinflammatory diseases.
The haemodynamic environment plays an important contributing role in the initiation and progression of ath-
erosclerosis, with disease developing and progressing most rapidly in regions of oscillatory, low and disturbed 
wall shear stress1–4. Underlying this response is the mechanosensitivity of endothelial cells, whose behaviour is 
profoundly modulated by the shear environment to which they are exposed. Athero-prone flow (disturbed flow 
pattern/oscillatory shear stress/low average wall shear stress) provokes endothelial dysfunction, reducing the bio-
availability of nitric oxide, while increasing oxidant stress, the magnitude of response to inflammatory cytokines, 
rates of apoptosis and permeability. The athero-protective phenotype that endothelial cells adopt in normal phys-
iological laminar shear stress (12–16 dynes/cm2 in the coronary circulation5–7) is predominantly mediated by 
increased expression of KLF2 and KLF4, and the activation of Nrf2, all of which combine to activate a program 
of gene expression and epigenetic changes that reduce endothelial dysfunction8,9. In addition, we have reported 
that endothelial cells cultured under elevated shear stress (75 dynes/cm2) similar to that experienced overlying 
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a stenotic atherosclerotic plaque adopt a unique phenotype10, which may therefore react in a different way to 
mediators of endothelial dysfunction. Under elevated shear stress, endothelial cells amplify many of the features 
observed at normal physiological flow, further increasing the expression of KLF2 and KLF410, however they have 
a distinctive transcriptomic and proteomic signature (10 and S. White, unpublished data).
TNFα imposes a significant pro-inflammatory effect on endothelial cells. It induces the expression of adhesion 
molecules (e.g. VCAM1, ICAM1, E-selectin) and chemokines (e.g. MCP1/CCL2 and fractalkine/CX3CL1)11, pre-
dominantly through activation of transcription factor NFκ B12,13. TNFα also increases the production of reactive 
oxygen species (ROS), perpetuating endothelial dysfunction. The responses to TNFα and other inflammatory 
mediators are ameliorated by shear stress, with KLF2 and Nrf2 inhibition of TNFα activity being part of the 
anti-inflammatory effects of laminar shear stress8,14,15. Nevertheless, endothelial cells over stenotic atherosclerotic 
plaques show markers of inflammation16, including increased adhesion molecule expression17,18, implying that 
the protective effects of flow may be over-ridden in advanced atherosclerosis.
Cigarette use also induces endothelial dysfunction, either indirectly by elevating circulating inflammatory 
cytokines, including TNFα , or directly by increasing oxidant stress19–22. We have previously demonstrated that 
fresh aqueous cigarette smoke extract (CSE) induces a stress response in human coronary artery endothelial cells, 
activating transcription factor Nrf2 and increasing the expression of cytochrome p450 subunits23.
In this report we demonstrate the use of our improved model for studying the prolonged effects of oscillatory, 
physiological and elevated flow. We focus on the interaction of shear stress with the effects of TNFα and CSE 
as a model of endothelial dysfunction, which contributes to the development of atherosclerosis, our intention 
being to identify new signalling interactions that might be useful ultimately for future therapy or as biomarkers. 
Consistent with this aim, we document the shear, TNFα and CSE-dependent upregulation of transcription factor 
ATF3, identifying a negative-feedback loop that limits proinflammatory gene expression.
Results
Effects of flow and cigarette smoke extract (CSE) on TNFα induced gene expression in different, 
sustained flow environments. We sought to use treatments with TNFα and cigarette smoke extract (CSE), 
alone or in combination, to mimic pathological effects on human coronary artery endothelial cells (HCAECs). 
We investigated the effects of sustained exposure under oscillatory (OSS), normal laminar (15 dynes/cm2 - LSS) 
or elevated laminar shear stress (75 dynes/cm2 - ESS). OSS models some components of athero-prone flow, LSS 
models athero-protective flow and ESS models flow overlying stenotic plaques. HCAECs were exposed to shear 
stress for 24 hours before 3 treatments of 5 ng/ml of TNFα , 10% v/v CSE, or the combination of both treatments 
were applied to the cells, 16 hours apart (Fig. 1H and supplementary data). The concentrations of mRNAs or 
proteins were measured 16 hours after the final treatment (48 hours of exposure to stimuli). This protocol allowed 
the HCAECs time to adapt to the flow environment before treatments were applied and captured the response 
to sustained exposure to these insults. In agreement with previous findings, TNFα significantly increased the 
expression of VCAM1 and other intercellular adhesion molecules ICAM1 and E-selectin, as well as cytokines 
CCL2 and CX3CL1 and the NFκ B feed-back regulator, Iκ Bα (Fig. 1A–G). The effect on VCAM-1 was confirmed 
at the protein level (Fig. 1B). Multiple studies have demonstrated that normal laminar shear stress reduces the 
magnitude of proinflammatory gene expression induced by TNFα treatment24–28. We failed to show a significant 
effect of normal laminar shear stress (LSS) on TNFα -regulated genes, possibly because of the sustained exposure 
to TNFα . However, we cannot rule out a subtle effect of LSS on TNFα -regulated genes, because the concur-
rent testing of multiple experimental conditions reduces the power to identify small changes in gene expression. 
CSE did not increase the expression of any of the pro-inflammatory genes investigated under any flow condi-
tion. Surprisingly, however, CSE antagonised the induction of these genes by TNFα under sustained LSS or ESS 
(Fig. 1A–G). We concluded, firstly, that sustained exposure to TNFα overwhelmed the ability of flow to reduce 
pro-inflammatory activation. Secondly, CSE appeared to evoke a response that suppressed expression of some 
pro-inflammatory genes, particularly under normal physiological or elevated laminar shear stress. By contrast, 
a few of the TNFα responsive genes assayed were not down-regulated by CSE. For example expression of pro-
tease inhibitor 3 (PI3) or the p65/RelA subunit of NF-κ B were stimulated by TNFα but not suppressed by CSE 
(Supplementary Figures 4, 5).
Effects of TNFα and CSE on the expression of shear responsive genes. Laminar shear stress has 
been shown to maintain high level expression of multiple athero-protective genes in endothelial cells through 
induction of transcription factors Kruppel-like factor-2 and 4 (KLF2, KLF4)8,29. We confirmed these observa-
tions in our experiments. For example, KLF2 expression was significantly enhanced in LSS and ESS compared 
to OSS (13- and 20-fold, respectively Fig. 2A). Similar results were found for KLF4 (33- and 100-fold, respec-
tively, Fig. 2B) and for shear stress responsive genes thrombomodulin (THBD), endothelial nitric oxide synthase 
(NOS3) and nephroblastoma overexpressed (NOV) (Fig. 2C–F). The effect on the mRNA expression of thromo-
modulin (THBD) correlated with the protein level (Fig. 2D). The effects of ESS always tended to be greater than 
LSS but this was only statistically significant for THBD and NOV (Fig. 2C,D,F). Most interestingly, although 
sustained treatment with TNFα did not affect the upregulation of either KLF2 or KLF4 mRNA, it significantly 
reduced the expression of THBD mRNA and protein, NOS3 and NOV mRNA. This implies that TNFα can antag-
onise the transcriptional responses to KLFs, without directly affecting their expression. Sustained treatment with 
CSE did not affect the upregulation of KLF2 or KLF4 mRNA either, nor did it rescue the TNFα suppression of 
shear-regulated genes. The anti-inflammatory effects of CSE are therefore unlikely to be mediated through KLF2 
or KLF4-dependent mechanisms.
CSE upregulates the expression of Nrf2 responsive genes at all shear rates. The transcription 
factor, Nrf2, is central to the antioxidant response in endothelial cells15,30–32, having been shown to increase the 
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expression of a group of genes that includes heme oxygenase 1 (HMOX1)23. Administration of cigarette smoke 
extract (CSE) significantly increased HMOX1 expression to a similar extent at mRNA and protein levels in all the 
shear environments we tested (Fig. 3A,B). CSE also increased the expression of the other antioxidant response 
genes (which are validated Nrf2 targets23,33) in HCAECs and in most cases the effects were amplified at the higher 
shear rates. By contrast, TNFα alone had no effect on any Nrf2 target gene studied at any shear rate (Fig. 3A–E). 
However, the addition of TNFα to CSE significantly enhanced the expression of sulfiredoxin 1 (SRXN1) and 
Figure 1. Effects of flow and cigarette smoke extract (CSE) on TNFα induced gene expression. The mRNA 
expression of (A) VCAM1, (C) ICAM1, (D) E-selectin, (E) CCL2, (F) CX3CL1 and (G) Iκ Bα , (n = 6 separate 
batches of HCAECs); or (B) protein expression of VCAM-1 (n = 3 separate batches of HCAECs). HCAEC were 
exposed to 5 ng/ml TNFα , 10% CSE or TNFα and CSE together (T + C) under OSS, LSS or ESS conditions, as 
illustrated schematically (H). Changes are expressed as mean fold change against LSS control ± S.E.M. *p < 0.05; 
**p < 0.01, ***p < 0.001 significant vs control for that shear stress, or other indicated comparison; #P < 0.05 vs 
OSS control
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oxidative stress induced growth inhibitor 1 (OSGIN1) at ESS. The anti-inflammatory effects of CSE could there-
fore be mediated by an Nrf2-dependent process.
Shear stress, TNFα and CSE modulate ATF3 expression. Transcription factor, ATF3, was previously 
shown to inhibit Toll-like receptor 4 (TLR4)-stimulated inflammatory response by repression of NFκ B responsive 
genes in macrophages34, potentially by localising inhibitory co-factors at the promoter. Therefore we investigated 
whether ATF3 expression was modulated in our system and could act as a suppressor of pro-inflammatory gene 
induction. LSS did not significantly increase ATF3 mRNA expression but ESS increased it 3.7-fold compared to 
LSS (Fig. 4A, note the logarithmic scale). CSE did not increase ATF3 expression at OSS or LSS but increased it 
at ESS (an additional 5-fold above ESS control Fig. 4A). TNFα tended to increase ATF3 expression at all shear 
stresses and this was significant at OSS and LSS (6.5-fold increase). CSE and TNFα produced synergistic effects 
at LSS and ESS (approximately 10-fold increases above CSE alone Fig. 4A). Hence, CSE, TNFα and ESS were 
all necessary to maximise the expression ATF3 in HCAECs. Importantly, the highest level of ATF3 expression 
(175-fold above LSS alone and 185-fold increase over OSS) was observed under the same conditions where proin-
flammatory gene expression showed the greatest inhibition (Fig. 1).
To investigate the regulation of ATF3, we used adenoviral overexpression of Nrf2 in static cultures of 
HCAECs. Adenoviral Nrf2 overexpression increased ATF3 expression. Consistent with the experiments under 
Figure 2. TNFα, but not CSE, suppress the expression of shear-responsive genes. Changes in mRNA 
expression (n = 6 batches) of (A) KLF2, (B) KLF4, (C) THBD, (E) NOS3, (F) NOV or (D) THBD protein 
(n = 3 batches) were measured in HCAECs exposed to 5 ng/ml TNFα , 10% CSE or TNFα and CSE together 
(T + C) under OSS, LSS or ESS, expressed as mean fold change against control ± S.E.M. *p < 0.05; **p < 0.01, 
***p < 0.001 significant vs control for that shear stress, or indicated comparison; ~~~P < 0.001 vs LSS and ESS 
(all conditions).
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flow (Fig. 4A), TNFα also stimulated ATF3 expression in static cultures (Fig. 4B). The effects of Nrf2 overexpres-
sion and TNFα stimulation were less than additive.
ATF3 reduces proinflammatory gene expression without reducing NFκB activation, nuclear 
entry, DNA binding or activation. We hypothesised that ATF3 may play a role in the down-regulation 
of TNFα stimulated pro-inflammatory genes. Consistent with this, adenoviral-mediated ATF3 overexpression 
significantly reduced the level of VCAM1 expression when HCAECs were stimulated with TNFα in static culture 
(Fig. 5A). ATF3 overexpression also altered the morphology of HCAECs, inducing an elongation, with no sign of 
induction of cell stress or apoptosis (Supplementary Figure 6). To investigate whether ATF3 interfered with NFκ B 
activation or activity, we created a lentiviral-based NFκ B luciferase reporter35 expression construct in endothelial 
cell line EA.hy926 (NF-EA.hy926). In NF-EA.hy926 cells, ATF3 overexpression again inhibited the TNFα upreg-
ulation of VCAM1 (Fig. 5B), but there was no effect of ATF3 overexpression on the TNFα -dependent upregula-
tion of luciferase (Fig. 5C), indicating that ATF3 overexpression did not prevent NFκ B activation, nuclear entry, 
DNA binding and ability to activate transcription of the reporter.
Discussion
Our model allowed HCAEC to adapt to their shear environment for 24 hours before treatment. Under these condi-
tions, repeated exposures to TNFα over a 48 hour period upregulated the expression of a panel of NFκ B responsive 
genes. Importantly, the anti-inflammatory effects of laminar shear that have been reported at shorter time points 
Figure 3. CSE increases the expression of Nrf2 responsive genes. Changes in mRNA expression of  
(A) HMOX1, (C) SRXN1, (D) GCLM, (E) OSGIN1, (F) NQO1 (n = 6 batches) or (B) HMOX1 protein (n = 3 
batches) in HCAECs exposed to 5 ng/ml TNFα , 10% CSE or TNFα and CSE together (T + C) under OSS, 
LSS or ESS conditions. Changes are expressed as mean fold change against LSS control ± S.E.M. *p < 0.05; 
**p < 0.01, ***p < 0.001 significant vs control for that shear stress, or indicated comparison; #P < 0.05 vs OSS 
control.
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in other models do not apparently persist after longer exposures to TNFα in our model. Instead, this study iden-
tified an unexpected inhibitory effect of repeated exposure to CSE on expression of a subset of pro-inflammatory 
genes. This effect correlated with the upregulation of Nrf2 rather than KLF2/4. Furthermore, TNFα , laminar shear 
and CSE synergised to induce the transcriptional inhibitor ATF3, which we showed to be an Nrf2 responsive gene. 
We found that ATF3 expression in HCAECs has a large dynamic range, with its expression increasing 185-fold 
between the highest and lowest conditions. Overexpression of ATF3 was shown to inhibit pro-inflammatory 
gene expression but independently of a direct effect on NFκ B activity. ATF3 upregulation therefore constitutes an 
NFκ B-independent protective mechanism that limits the expression of proinflammatory genes.
ATF3 is upregulated in a multitude of stressed tissues36, hypoxic conditions37 and some, but not all cancers38–40, 
where its actions promote metastasis41. As a homodimer, ATF3 binds to the cyclic AMP response element and 
represses transcription42, potentially by localising inhibitory co-factors at the promoter. Gilchrist et. al. demon-
strated that, in macrophages, ATF3 expression was induced by LPS treatment and inhibited TLR4-stimulated 
inflammatory responses as part of a negative-feedback loop34. Interestingly, they showed the predominant 
inhibitory action was seen where ATF3 binding sites closely apposed NFκ B binding sites, which was supported 
by chromatin immunoprecipitation experiments. We therefore, think it is most likely that ATF3 upregulation 
and inhibition of NFκ B-mediated transcription, is the mechanism responsible for the anti-inflammatory effect 
elicited by CSE in HCAEC. Furthermore, macrophages from ATF3−/− mice responded more vigorously to LPS 
treatment and suffered greater mortality to LPS challenge, suggesting a general role for ATF3 in dampening 
inflammation. Consistent with these results, we observed that adenoviral-mediated overexpression of ATF3 
inhibited TNFα -dependent VCAM1 expression. This may be context specific as another group demonstrated 
that ATF3, in concert with TGFβ signalling43, increased pro-inflammatory gene expression. The action of NFκ 
B is very context specific and regulates both prosurvival and proinflammatory gene expression44, further work is 
needed to identify which NFκ B responsive genes are subject to ATF3-mediated repression. KLF4 was also shown 
to repress VCAM1 expression45, but because CSE did not alter KLF4 mRNA levels or downstream gene expres-
sion, it is unlikely that KLF4 contributes to the anti-inflammatory effects of CSE.
In contrast to previous reports, we did not observe a reduction in KLF2 or KLF4 expression with TNFα treat-
ment. NFκ B triggered the recruitment of HDAC4 and 5 to the promoter of KLF2 reducing its expression in static 
culture in HUVEC46. This suggests that prolonged shear stress may reduce the recruitment of HDAC4 and 5 to 
the promoter of KLF2, or that there is a difference in the response of HUVEC and HCAEC to TNFα treatment. 
Additionally, while TNFα induced an increase in ROS production (sup Fig. 3A), this ROS did not activate Nrf2 
responsive genes (Fig. 3). This suggests a specific localisation or type of ROS is necessary for Nrf2 activation. CSE 
is known to contain very high levels of free radicals47,48, indicating Nrf2 activation is much more sensitive to this 
Figure 4. Shear stress, TNFα and CSE all increase ATF3 expression. Changes in (A) ATF3 mRNA expression 
in HCAECs exposed to 5 ng/ml TNFα , 10% CSE or TNFα and CSE together (T + C) under OSS, LSS or ESS, 
expressed as mean fold change against control ± S.E.M. *p < 0.05; **p < 0.01, ***p < 0.001 significant vs control 
for that shear stress, or indicated comparison; #P < 0.05 vs OSS control; n = 6 batches. (B) Regulation of ATF3 
mRNA expression in HCAECs following transduction with adenoviral vector overexpressing Nrf2, treatment 
with 5 ng/ml TNFα , or the combination in static culture. **P < 0.01 vs Untreated Control; +++P < 0.001 vs β -gal 
adenoviral vector control.
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rather than endogenously generated ROS. There is also the possibility of cell-specific effects in this regard, as 
TNFα was shown to activate Nrf2 in macrophages49.
Our data hints at the potential of using local upregulation of ATF3 as a new avenue for treating inflammatory 
diseases. While the detrimental effects of smoking are well documented (tobacco contributes to the deaths of up 
to half of its users – World Health Organisation statistics), there are a few pathologies where it has been shown 
that smoking reduces the severity of the symptoms. For example, ulcerative colitis50, recurrent aphthous stoma-
titis51, Behçet’s disease52 (which is noted to flare up on cessation of smoking) and Parkinson’s disease53 (where 
smoking has a protective effect on the development of symptoms). While the detrimental effects of smoking far 
outweigh any beneficial effects, our work suggests that part of the protective effect in these select group patholo-
gies might be mediated through ATF3 upregulation by cigarette smoke; however further investigation would be 
needed to support this hypothesis. Directly augmenting ATF3 expression, using localised gene transfer or appli-
cation of Nrf2 agonists54–56, could offer therapeutic potential by bypassing the damaging effects of free radicals 
generated in tobacco combustion.
Our in vitro model has the advantage that endothelial cells have time to adapt to their shear environment 
before treatments are applied. This prevents any treatment from interfering with the adaptation process, which 
might be a confounding factor where the treatments are applied at the commencement of flow. The extended 
nature of these flow experiments does however preclude pre-treatment with agents that limit endothelial pro-
liferation, as we aim to start with a completely confluent monolayer of cells. CSE was generated by bubbling fil-
tered mainstream smoke through tissue culture media23. This captured the water-soluble components of cigarette 
smoke, which was filtered to remove particulate matter and immediately applied to cells, to prevent the quenching 
of dissolved free radicals. The water-soluble components of cigarette smoke have greater relevance for the study of 
the systemic effects of cigarette smoke, although it is not possible to assess if CSE generated in this way captures 
the same components of cigarette smoke that are capable of passing through the lungs into the blood stream. 
In addition, the CSE is administered to cells as a bolus every 16 hours, because of the experimental complexity 
of administering smaller doses at shorter time intervals. This very approximately equates to an average person 
smoking 25 cigarettes23.
In conclusion, this study has identified a novel anti-inflammatory pathway in HCAECs that is synergistically 
activated by TNFα , laminar shear and aqueous CSE and is capable of significantly downregulating adhesion 
Figure 5. ATF3 overexpression reduces VCAM1 upregulation. (A) Adenoviral-mediated ATF3 
overexpression reduced TNFα -stimulated VCAM1 upregulation in HCAEC. (B) In NFκ B reporter endothelial 
cell line NF-EA.hy926, ATF3 overexpression reduced TNFα -stimulated VCAM1 mRNA upregulation; however 
did not inhibit NFκ B reporter activity (C), measured by changes in luciferase mRNA expression. *P < 0.05 vs 
untreated control; †††P < 0.001 vs no virus + TNFα or β -gal viral control + TNFα ; n = 3.
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molecule and inflammatory cytokine expression. Furthermore, this effect can be recapitulated by the upregula-
tion of transcription factor ATF3.
Methods
Cell culture. Human coronary artery endothelial cells (HCAECs, PromoCell, passage 3 to 6) were cultured 
in endothelial cell growth medium kit (MV2, PromoCell) with the addition of 100 U/ml penicillin/streptomycin. 
For flow experiments, HCAECs were seeded at 2. 5 × 105 cells/slide onto gelatin coated glass slides within sterile 
silicon gaskets that limited cell attachment to the central portion of the slide (~9 cm2). Cells were grown within 
the gaskets on the slides for a minimum of 72 hours prior to flow to ensure a completely confluent monolayer and 
allow maturation of cell-cell and cell-matrix interactions. The slide was assembled aseptically into a previously 
described parallel plate flow apparatus10 for exposure to oscillatory (OSS, 0 ± 5 dynes), laminar shear stress − 15 
dynes/cm2 (LSS), or elevated laminar shear stress − 75 dynes/cm2 (ESS) for 72 hours. Cells were exposed to shear 
stress for 24 hours prior to any treatment to allow them to adapt to their shear environment and adopt the relevant 
phenotype. Cigarette smoke extract (CSE) was prepared, filter sterilized using 0.20 μ m filter and used immediately 
upon creation as described23. Briefly, CSE was created using ~385 ml of mainstream smoke (7–8 average puffs) 
from a single Marlboro Gold cigarette (7 mg tar, 0.6 mg nicotine) drawn through 10 ml of media MV2 at a rate 
of 70 ml/min. HCAECs were treated with 5 ng/ml tumour necrosis factor-alpha (TNFα , Milteny Biotech) and/or 
10% CSE for 48 hours (total of 3 treatments, one every 16 hours, with cells analysed 16 hours after the last treat-
ment, see Fig. 1H). For all flow experiments, MV2 media was made up omitting hydrocortisone and additional 
ascorbic, acid and supplemented with 3.35% dextran (31390-Sigma) to raise the viscosity to 1.5 cP, equivalent to 
plasma.
Viral transduction. Wild type Nrf2 adenovirus (AdNrf215) was generous gifts from Professor Paul Evans 
(Sheffield University, UK). ATF3 overexpressing adenovirus (AdATF3) was created by PCR amplification 
of cDNA with SW706F/707 R (See the online supplement), and cloned into BglII/NheI sites of CpG-free-mcs 
(Invivogen). The whole expression cassette was then shuttled into pDC511 (Microbix Biosystems, Canada) by 
EcoRI digest. The β -galactosidase (β -gal) control adenovirus (Adβ -gal) was made by cloning the EcoRI digest 
fragment containing the same expression cassette and β -galactosidase gene from CpG-LacZ (Invivogen) into 
pDC511. Both were then produced using the Microbix Biosystems kit according to their protocols. Optimal 
transduction of HCAEC was achieved using 300 PFU/cell overnight. NFκ B reporter cell line NF-EA.hy926 was 
created by transducing the endothelial cell line EA.hy926 with a lentiviral vector containing 8 repeats of a NFκ B 
binding site (GGGACTTTCC) minimal promoter and FLAG-Luc-2A-eGFP insert as described35.
Western Blotting. Western blots were performed on SDS protein lysates quantified by picogreen assay, 
as described10. Lysates that contained 10,000 cells were resolved on SDS polyacrylamide gels, before transfer-
ring onto PVDF membranes and probing with primary antibodies overnight at 4 °C. Antibodies used: VCAM1 
(AF643, R&D), THMB (Ab109189, Abcam), HMOX1 (Ab52947, Abcam), NFκ B (#8242, Cell Signalling), NFκ B 
pSer536 (#3033, Cell Signalling).
Quantitative PCR. Quantitative PCR was performed using the Roche SYBR green PCR mastermix on 
cDNA prepared using the QuantiTect Reverse Transcription Kit (Qiagen). Primers are listed in the supplemen-
tary methods.
Statistics. Statistical analyses were performed using a one way ANOVA with Tukey-Kramer post hoc tests, 
or two-way ANOVA for experiments combining shear stress and exposure to TNFα or CSE, with Bonferroni 
post-test. *p < 0.05; **p < 0.01, ***p < 0.001.
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